cataract. cataract Excluded: capsular glaucoma with pseudo exfoliation of lens
Conditions
Interventions
Intervention 1: Propofol 1%, made in Dongkook Pharma. Co. Ltd. South Korea, 0.3 mg/kg that is used in IV injection one time for anesthesia induction. Intervention 2: Propofol 1%, made in Dongkook Phar
Treatment - Drugs
Propofol 1%, made in Dongkook Pharma. Co. Ltd. South Korea, 0.3 mg/kg that is used in IV injection one time for anesthesia induction
Propofol 1%, made in Dongkook Pharma. Co. Ltd. South Korea, 0.5 mg/kg/hr IV infusion
Intervention 1. Fentanyl (feniject), made in Aburaihan Pharma. Co. Iran, 1 µg/kg IV injection.
Intervention 2. Alfentanil, made in Hameln pharmaceuticals. Co. Ltd. Germany, 1 µg/kg IV injection.
Sponsors
Arak University of Medical Sciences,Vice Chancellor for Research
Eligibility
Sex/Gender
All
Age
18 Years to 149 Years
Inclusion criteria
Inclusion criteria: inclusion criteria: patient older than 18 years old Exclusion criteria: History of cardiovascular disease, History of neuromuscular disorder, History of allergic reaction to anesthetic drugs, history of previous surgery on eye
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Amount of eye movement. Timepoint: At time 0, 10 and 30 after beginning surgery. Method of measurement: quality grading. | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood pressure. Timepoint: At time 0, 10 and 30 minutes after beginning surgery. Method of measurement: Mercury sphygmomanometer according to mmHg.;Heart rate. Timepoint: At time 0, 10 and 30 minutes after beginning surgery. Method of measurement: beat per minute.;Temperature. Timepoint: At time 0, 10 and 30 minutes after beginning surgery. Method of measurement: Mercury Termometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Esmaiel Moshiri
Arak University of Medical Sciences
Outcome results
None listed